NO141341C - Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivat - Google Patents
Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivatInfo
- Publication number
- NO141341C NO141341C NO741142A NO741142A NO141341C NO 141341 C NO141341 C NO 141341C NO 741142 A NO741142 A NO 741142A NO 741142 A NO741142 A NO 741142A NO 141341 C NO141341 C NO 141341C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- benzopyran derivative
- analogy procedure
- active benzopyran
- Prior art date
Links
- 150000001562 benzopyrans Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34837173A | 1973-04-05 | 1973-04-05 | |
| US05/442,033 US4049653A (en) | 1973-04-05 | 1974-02-13 | Heterocyclic esters of alkylphenyl benzopyrans |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO741142L NO741142L (no) | 1974-10-08 |
| NO141341B NO141341B (no) | 1979-11-12 |
| NO141341C true NO141341C (no) | 1980-02-20 |
Family
ID=26995674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO741142A NO141341C (no) | 1973-04-05 | 1974-03-29 | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivat |
Country Status (13)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2615397A1 (de) * | 1976-04-08 | 1977-10-27 | Sharps Ass | Neue benzopyranester |
| US4133819A (en) * | 1977-06-17 | 1979-01-09 | Pfizer Inc. | Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents |
| US4243674A (en) * | 1978-06-12 | 1981-01-06 | Pfizer Inc. | 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore |
| US4454144A (en) * | 1982-06-21 | 1984-06-12 | Pfizer Inc. | Substituted dibenzo[b,d]pyran analgesics |
| US5498419A (en) * | 1994-06-03 | 1996-03-12 | Pars; Harry G. | Fumarate salt of 4-(diethyl-3-(1-methyloctyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, 4-(diethyl-amino) butyric |
| DE19706903A1 (de) | 1997-02-21 | 1998-08-27 | Bayer Ag | Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1 |
| US6187203B1 (en) * | 1998-12-01 | 2001-02-13 | Academia Sinica | Sample purification apparatus and method |
| WO2008114732A1 (ja) * | 2007-03-16 | 2008-09-25 | Shiseido Company Ltd. | しわ防止・改善剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3880885A (en) * | 1971-11-23 | 1975-04-29 | Sandoz Ag | Tertiary aminoethyl isochromans and isocoumarins |
| US3984419A (en) | 1972-06-21 | 1976-10-05 | E. R. Squibb & Sons, Inc. | Perhydrofluorenetetrol and perhydro-phenanthrenetetrol derivatives |
-
1974
- 1974-02-13 US US05/442,033 patent/US4049653A/en not_active Expired - Lifetime
- 1974-03-14 AU AU66649/74A patent/AU476698B2/en not_active Expired
- 1974-03-27 NL NL7404147A patent/NL7404147A/xx not_active Application Discontinuation
- 1974-03-29 NO NO741142A patent/NO141341C/no unknown
- 1974-04-01 CA CA196,458A patent/CA1038383A/en not_active Expired
- 1974-04-01 SE SE7404388A patent/SE413191B/xx unknown
- 1974-04-02 JP JP49036719A patent/JPS5035169A/ja active Pending
- 1974-04-02 PH PH15684A patent/PH13583A/en unknown
- 1974-04-03 FI FI1027/74A patent/FI60007C/fi active
- 1974-04-03 GB GB1485374A patent/GB1459943A/en not_active Expired
- 1974-04-04 FR FR7412012A patent/FR2224157B1/fr not_active Expired
- 1974-04-04 DE DE2416491A patent/DE2416491C3/de not_active Expired
- 1974-04-05 CH CH479774A patent/CH592086A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1459943A (en) | 1976-12-31 |
| NO141341B (no) | 1979-11-12 |
| FI60007B (fi) | 1981-07-31 |
| AU476698B2 (en) | 1976-09-30 |
| AU6664974A (en) | 1975-09-18 |
| FR2224157A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-10-31 |
| DE2416491B2 (de) | 1979-06-28 |
| US4049653A (en) | 1977-09-20 |
| PH13583A (en) | 1980-07-16 |
| NO741142L (no) | 1974-10-08 |
| SE413191B (sv) | 1980-04-28 |
| FR2224157B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-05-06 |
| JPS5035169A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-04-03 |
| CA1038383A (en) | 1978-09-12 |
| DE2416491A1 (de) | 1974-10-24 |
| CH592086A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-10-14 |
| NL7404147A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-10-08 |
| FI60007C (fi) | 1981-11-10 |
| DE2416491C3 (de) | 1981-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| NO144885C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO147148C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater | |
| NO145576C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater | |
| NO142304C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater | |
| NO152751C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat. | |
| NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
| NO149281C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater | |
| NO143846C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater | |
| NO145791C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
| NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
| NO142303C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater | |
| NO140597C (no) | Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater | |
| NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| NO141341C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivat | |
| NO142260C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater | |
| NO143664C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive dibenzofuranforbindelser | |
| NO145620C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere. | |
| NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
| NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
| NO141441C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on | |
| NO147523C (no) | Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat | |
| NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
| NO147754C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater. |